#Peptide Microarray Market Share | Explore Tumblr posts and blogs

healthcare-updates-with-sns · 3 months ago

Text

Peptide Microarray Market: Market Trends and Future Outlook 2024-2032

The global peptide microarray market is expected to witness significant growth in the coming years due to the increasing adoption of personalized medicine, advancements in biotechnology, and the rising need for efficient and high-throughput screening methods. Peptide microarrays are widely used for various applications, including biomarker discovery, drug development, disease diagnostics, and immunology research. These arrays enable researchers to study protein-peptide interactions, making them indispensable tools in molecular biology and biochemistry.

Get Free Sample Report @ https://www.snsinsider.com/sample-request/4098

Market Segmentation

The peptide microarray market is segmented based on the following categories:

By Type:

Analytical Peptide Microarrays: These are primarily used in drug discovery, disease diagnostics, and proteomics research.

Functional Peptide Microarrays: Focused on studying peptide functions in relation to specific diseases and biological processes.

By Application:

Drug Discovery: Peptide microarrays are used to identify bioactive peptides for drug development.

Diagnostics: Utilized for identifying biomarkers and conducting diagnostic tests for various diseases.

Research and Development: Peptide microarrays support academic and clinical research in the fields of molecular biology, biochemistry, and immunology.

By End-User:

Pharmaceutical and Biotechnology Companies: Peptide microarrays help in drug discovery, biomarker identification, and disease management.

Academic and Research Institutes: These institutions use peptide microarrays for scientific studies and experimental applications.

By Region:

North America: Dominates the peptide microarray market due to the presence of advanced research facilities and a strong healthcare infrastructure.

Europe: Shows significant growth with increasing research in personalized medicine and biotechnology.

Asia Pacific: Expected to witness rapid growth due to increased investments in healthcare, biotechnology, and drug development.

Rest of the World: Other regions, including Latin America and the Middle East, are also emerging as key markets due to increased awareness and healthcare advancements.

Regional Analysis

The peptide microarray market is geographically segmented into North America, Europe, Asia Pacific, and the rest of the world. North America holds a substantial market share, driven by the region’s advanced healthcare infrastructure, rising healthcare expenditures, and prominent biotechnology and pharmaceutical companies. Europe follows closely, with substantial research efforts in personalized medicine and drug development. The Asia Pacific region is anticipated to grow rapidly in the coming years, fueled by increasing investments in biotechnology, healthcare advancements, and expanding pharmaceutical industries.

Key Players

The major players are PEPperPRINT GmbH, RayBiotech Life, Inc., Creative Biolabs, Aurora Instruments Ltd., Kinexus Bioinformatics Corp., Pfizer Inc., Microarrays Inc., Bio-Rad Laboratories, JPT Peptide Technologies, Merck KGaA, Innopsys, and Others.

Key Points

Increasing demand for personalized medicine is a key driver of the market.

The peptide microarray market is growing due to the rising applications in drug discovery, diagnostics, and R&D.

North America is the dominant region, with Europe and Asia Pacific showing strong growth potential.

The market is being driven by advances in biotechnology, drug development, and precision medicine.

Technological advancements in microarray technology are enhancing the efficiency and capabilities of peptide microarrays.

Future Scope

The peptide microarray market is poised for continued expansion, with several future opportunities on the horizon. Innovations in peptide synthesis, increased integration with AI and machine learning for data analysis, and a greater emphasis on personalized medicine are expected to drive market growth. The demand for more accurate, high-throughput, and cost-effective diagnostic tools is also expected to create new avenues for growth. As the biotechnology and pharmaceutical sectors advance, the use of peptide microarrays in clinical settings will likely increase, leading to more widespread adoption and a broader application base in disease research, diagnostics, and therapeutic development.

Conclusion

In conclusion, the peptide microarray market is experiencing robust growth, driven by technological advancements and the increasing adoption of personalized medicine. Key sectors such as drug discovery, diagnostics, and R&D are benefiting from the capabilities of peptide microarrays. With continued innovation and increasing applications across various industries, the market is set to grow at a substantial pace in the coming years. As research and development continue to evolve, peptide microarrays will play a vital role in advancing scientific knowledge and improving healthcare outcomes.

Other Related Reports:

Cell Viability Assay Market

Medical Power Supply Market

Post Traumatic Stress Disorder Treatment Market

MRI Guided Neurosurgical Ablation Market

#Peptide Microarray Market #Peptide Microarray Market Share #Peptide Microarray Market Size #Peptide Microarray Market Trends #Peptide Microarray Market Growth

0 notes

bhavesh2022 · 5 months ago

Text

North America Sepsis Diagnostics Market Growth Analysis, Key Players

Business Market Insights recently announced the release of the market research titled North America Sepsis Diagnostics Market Outlook to 2028 | Share, Size, and Growth. The report is a stop solution for companies operating in the North America Sepsis Diagnostics market. The report involves details on key segments, market players, precise market revenue statistics, and a roadmap that assists companies in advancing their offerings and preparing for the upcoming decade. Listing out the opportunities in the market, this report intends to prepare businesses for the market dynamics in an estimated period.

Is Investing in the Market Research Worth It?

Some businesses are just lucky to manage their performance without opting for market research, but these incidences are rare. Having information on longer sample sizes helps companies to eliminate bias and assumptions. As a result, entrepreneurs can make better decisions from the outset. North America Sepsis Diagnostics Market report allows business to reduce their risks by offering a closer picture of consumer behavior, competition landscape, leading tactics, and risk management.

A trusted market researcher can guide you to not only avoid pitfalls but also help you devise production, marketing, and distribution tactics. With the right research methodologies, Business Market Insights is helping brands unlock revenue opportunities in the North America Sepsis Diagnostics market.

If your business falls under any of these categories – Manufacturer, Supplier, Retailer, or Distributor, this syndicated North America Sepsis Diagnostics market research has all that you need.

What are Key Offerings Under this North America Sepsis Diagnostics Market Research?

Global North America Sepsis Diagnostics market summary, current and future North America Sepsis Diagnostics market size

Market Competition in Terms of Key Market Players, their Revenue, and their Share

Economic Impact on the Industry

Production, Revenue (value), Price Trend

Cost Investigation and Consumer Insights

Industrial Chain, Raw Material Sourcing Strategy, and Downstream Buyers

Production, Revenue (Value) by Geographical Segmentation

Marketing Strategy Comprehension, Distributors and Traders

Global North America Sepsis Diagnostics Market Forecast

Study on Market Research Factors

Who are the Major Market Players in the North America Sepsis Diagnostics Market?

North America Sepsis Diagnostics market is all set to accommodate more companies and is foreseen to intensify market competition in coming years. Companies focus on consistent new launches and regional expansion can be outlined as dominant tactics. North America Sepsis Diagnostics market giants have widespread reach which has favored them with a wide consumer base and subsequently increased their North America Sepsis Diagnostics market share.

Report Attributes

Details

Segmental Coverage

Product

Instruments

Reagents and Assays

Blood Culture Media

and Software

Technology

Molecular Diagnostics (Polymerase Chain Reaction

Peptide Nucleic Acid-Fluorescent in Situ Hybridization

Syndromic Panel-Based Testing

and Microarrays)

Flow Cytometry

Microfluidics

Immunoassay

Method

Automated Diagnostics and Conventional Diagnostics

Test Type

Point-of-Care Tests and Laboratory Tests

End User

Bacterial Sepsis

Fungal Sepsis

and Others

Regional and Country Coverage

North America (US, Canada, Mexico)

Europe (UK, Germany, France, Russia, Italy, Rest of Europe)

Asia Pacific (China, India, Japan, Australia, Rest of APAC)

South / South & Central America (Brazil, Argentina, Rest of South/South & Central America)

Middle East & Africa (South Africa, Saudi Arabia, UAE, Rest of MEA)

Market Leaders and Key Company Profiles

Abbott

bioMerieux SA

Danaher (Beckman Coulter)

F. HOFFMANN-LA ROCHE LTD.

Immunexpress Inc.

Luminex Corporation

T2 Biosystems, Inc.

THERMO FISHER SCIENTIFIC INC.

Other key companies

What are Perks for Buyers?

The research will guide you in decisions and technology trends to adopt in the projected period.

Take effective North America Sepsis Diagnostics market growth decisions and stay ahead of competitors

Improve product/services and marketing strategies.

Unlock suitable market entry tactics and ways to sustain in the market

Knowing market players can help you in planning future mergers and acquisitions

Visual representation of data by our team makes it easier to interpret and present the data further to investors, and your other stakeholders.

Do We Offer Customized Insights? Yes, We Do!

The Business Market Insights offer customized insights based on the client’s requirements. The following are some customizations our clients frequently ask for:

The North America Sepsis Diagnostics market report can be customized based on specific regions/countries as per the intention of the business

The report production was facilitated as per the need and following the expected time frame

Insights and chapters tailored as per your requirements.

Depending on the preferences we may also accommodate changes in the current scope.

#North America Sepsis Diagnostics Market #Sepsis Diagnostics Market

0 notes

healthcaremarketanalysis · 8 months ago

Text

RNA Analysis Industry worth $9.9 billion by 2028, with a CAGR of 13.4%

The global RNA analysis market growth forecasted to transform from USD 5.3 billion in 2023 to USD 9.9 billion by 2028, driven by a CAGR of 13.4%. Various elements such as increasing R&D activities, increasing government funding for drug discovery research, and growing pharmaceutical & biological industries are the major growth factors for this market. Many peptide-based research projects are also being fostered by increasing collaborative partnerships among various companies that are driving market growth.

Download an Illustrative overview:

Browse in-depth TOC on "RNA Analysis Market"

178 - Tables

46 - Figures

263 - Pages

The reagents/consumables segment accounted for the largest share of the product & service segment in the RNA analysis market in 2022.

Based on product & service, the RNA analysis market is segmented into reagents/consumables, instruments, software, and services. In 2022, the reagents/consumables segment accounted for the largest share of the RNA analysis market. The large share of this segment is fueled by the increasing demand for omics-based therapeutics, expanding research and development activities, and the availability of various RNA analysis reagents in the market.

The PCR segment accounted for the largest share of the technology segment in the RNA analysis market in 2022.

Based on technology, the RNA analysis market is segmented into PCR, sequencing, microarrays, and RNA interference. The PCR segment accounted for the largest share in the RNA analysis market in 2022. PCR is associated with several advantages, such as ease of operation, and short production cycles. These advantages support the growth of the PCR in the RNA analysis segment.

Asia Pacific is likely to grow at the highest growth rate during the forecast period.

Based on the region The global RNA analysis market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is the largest regional segment. The Asia Pacific region is estimated to grow at the highest CAGR in the RNA analysis market during the forecast period. The growth of the pharmaceuticals market in the region is primarily driven by the increasing prevalence of chronic diseases, the rising disposable incomes, the growing focus on personalized medicine, and the increasing government support for genomics and proteomics.

Request Sample Pages:

RNA Analysis Market Dynamics:

Drivers:

Growing demand for personalized medicine

Restraints:

High capital investments

Opportunities:

Opportunities in Emerging Countries

Challenges:

Data management in transcriptomics research

Key Market Players:

The prominent players operating in the RNA analysis market are Thermo Fisher Scientific, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US), Illumina, Inc. (US), and Eurofins Scientific (Luxembourg).

Recent Developments:

In October 2022, Agilent Technologies and CMP Scientific Corp. entered into a co-marketing agreement to provide an integrated capillary electrophoresis-mass spectrometry (CE-MS) solution for the life science and pharmaceutical industries.

In March 2022, Eurofins acquired Beacon Discovery, a drug discovery-based CRO. Beacon supported the fully integrated drug discovery programs from target validation to pre-clinical candidates.

In January 2021, Thermo Fisher acquired Phitonex to provide greater flow cytometry and imaging multiplexing capabilities for protein and cell analysis research needs. Phitonex's product offerings are also an expansion of the company's existing protein and cell analysis portfolio.

Get 10% Free Customization on this Report:

RNA Analysis Market Advantages:

Unraveling Gene Expression: RNA analysis allows researchers to study the dynamic gene expression patterns in cells and tissues, providing valuable insights into how genes are regulated and how they respond to different stimuli, disease conditions, or treatments.

Disease Understanding: By analyzing RNA profiles, scientists can gain a deeper understanding of the molecular basis of various diseases, including cancer, neurological disorders, and infectious diseases. This knowledge can lead to the identification of biomarkers and potential therapeutic targets.

Personalized Medicine: RNA analysis has the potential to enable personalized medicine approaches. By profiling an individual's RNA, clinicians can tailor treatments to the patient's specific genetic makeup and disease characteristics, increasing treatment efficacy and minimizing adverse effects.

Advancements in Therapeutics: RNA analysis plays a crucial role in the development of novel RNA-based therapeutics, such as RNA interference (RNAi) and mRNA vaccines. These groundbreaking treatments have the potential to target specific genes and revolutionize disease management.

Diagnostic Applications: RNA analysis offers a wide range of diagnostic applications. From detecting infectious agents to identifying specific genetic mutations associated with diseases, RNA-based diagnostic tests can provide faster, more accurate results than traditional methods.

Biotechnology and Drug Development: In the biotechnology and pharmaceutical industries, RNA analysis is utilized to assess the safety and efficacy of potential drugs. It helps identify potential drug targets and provides valuable information during preclinical and clinical trials.

Agricultural Advancements: RNA analysis is also applied in agriculture to improve crop yields, develop disease-resistant varieties, and enhance the nutritional content of food.

Non-Invasive Testing: In certain cases, RNA analysis can be performed on non-invasive samples such as blood, urine, or saliva, reducing the need for invasive procedures and making it easier to monitor patients over time.

Technological Advancements: The RNA analysis market is continuously evolving with advancements in sequencing technologies, bioinformatics, and automation. These innovations have led to increased throughput, reduced costs, and improved accuracy in data analysis.

Research Tools: The availability of diverse RNA analysis tools and kits allows researchers to perform experiments efficiently and cost-effectively, fostering a broader adoption of RNA-focused studies across academic and commercial laboratories.

Overall, the growing advantages of RNA analysis have positioned it as a pivotal component in advancing our understanding of biology, driving medical breakthroughs, and shaping the future of personalized medicine and precision healthcare.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Contact:

Mr. Rohan Salgarkar

MarketsandMarkets Inc.

1615 South Congress Ave.

Suite 103, Delray Beach, FL 33445

USA : 1-888-600-6441

UK +44-800-368-9399

Email: [email protected]

Visit Our Website: https://www.marketsandmarkets.com/

#RNA Analysis Market

0 notes

poonamcmi · 11 months ago

Text

Peptide Synthesis Market to Grow Substantially owing to Wide Applications in Pharmaceutical Sector

The peptide synthesis market has gained major traction in recent years due to the wide applications of peptides in pharmaceutical development and research. Peptides are short chains of amino acids that can regulate numerous biological processes in humans. The peptide synthesis process involves the step-by-step fabrication of custom peptides as per research needs through chemical or enzymatic reactions. Peptides find applications as therapeutic drugs, diagnostics, vaccine development, and other biomedical applications. Technological advancements in peptide synthesis equipment and growing outsourcing of peptide production work to specialized contract manufacturing organizations are supporting the growth of the peptide synthesis industry.

The Global peptide synthesis market is estimated to be valued at US$ 490.58 Mn in 2024 and is expected to exhibit a CAGR of 7.4% over the forecast period 2024 To 2031.

Key Takeaways

Key players operating in the peptide synthesis market are GenScript Biotech Corporation, Merck KGaA, ThermoFisher Scientific Inc., Syngene, Lonza, Novo Nordisk A/S, Bachem Holding AG, Gyros Protein Technologies, Creative Diagnostics, CEM Corporation, PuroSynth. These players are focusing on capacity expansion and new product launches to strengthen their market presence.

There is a huge opportunity for developing novel peptide-based drugs for the treatment of chronic diseases like cancer, diabetes, and cardiovascular diseases. Many biopharma companies are actively investing Peptide Synthesis Market Trends discovery and development. Growing outsourcing of custom peptide synthesis jobs to contract manufacturing organizations is opening new revenue streams for market players.

The global expansion of major peptide synthesis companies through partnerships, acquisitions, and direct investments in emerging markets will help penetrate untapped opportunities. Asia Pacific and Middle East regions are witnessing major investments by key players to manufacture peptides for clinical research and commercial applications.

Market drivers

The major market driver is the wide applications of peptides in the pharmaceutical industry for developing novel drugs and diagnostics. Peptides have certain advantages over small molecule drugs such as high selectivity and potency. Moreover, the increasing incidence of chronic diseases worldwide is propelling pharmaceutical and biotech companies to focus on peptide-based therapeutics development. Growing R&D expenditure on proteomics and genomic research involving peptide synthesis techniques is another key factor supporting the market growth.

PEST Analysis

Political: The regulation policies of government regarding R&D activities and funding are expected to have a positive impact on the Peptide Synthesis Market Size And Trends Various government initiatives are promoting the growth of pharmaceutical and biotechnology sectors.

Economic: The increasing healthcare expenditure globally and availability of funding for research activities are the major macroeconomic factors augmenting the market growth. The rising disposable income is also driving the demand for advanced treatment options.

Social: Growing awareness about healthcare and rising prevalence of chronic diseases such as cancer, metabolic disorders are fueling the demand for peptide drugs and therapeutics. Advancements in proteomics and genomics are further supporting research activities in this field.

Technological: Adoption of innovative techniques like microarray peptide synthesis and high throughput peptide synthesis is accelerating the research process. Automation and use of robotics in synthesis is improving productivity and minimizing production costs.

The peptide synthesis market in terms of value is concentrated majorly in North America and Europe. North America alone holds around 40% of the global market share due to presence of advanced research infrastructure and major players in the US and Canada.

The Asia Pacific region is considered as the fastest growing market for peptide synthesis.This is attributed to increasing investments by market players, rapid economic development, growing biologics industry and rising focus on healthcare by governments in emerging countries like India and China. The governments are focusing on developing local manufacturing capabilities to reduce dependency on other regions. Get More Insights On, Peptide Synthesis Market About Author: Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)

#Peptide Synthesis Market Demand #Peptide Synthesis Market Size #Peptide Synthesis Market Trends #Peptide Synthesis #Peptide Synthesis Market

1 note · View note

priyanshisingh · 2 years ago

Text

Molecular Diagnostics Instruments Market Global industry share, growth, drivers, emerging technologies, and forecast research report 2030

The latest market report published by Credence Research, Inc. “Global Molecular Diagnostics Instruments Market: Growth, Future Prospects, and Competitive Analysis, 2022 – 2030. The global demand for molecular diagnostics instruments was valued at USD 15.9 Billion in 2022 and is expected to reach USD 34.4 Billion in 2030, growing at a CAGR of 11.7% between 2023 and 2030.

Molecular diagnostics instruments play a crucial role in the field of medical diagnostics by enabling the detection and analysis of genetic material, proteins, and other molecules associated with diseases. These instruments are used to identify specific genetic mutations, pathogens, and biomarkers, aiding in early disease detection, personalized medicine, and treatment monitoring.

Molecular Diagnostics Instruments Market Dynamics refer to the ever-evolving nature of the market for instruments used in molecular diagnostics. This field encompasses a wide range of technologies and techniques that analyze biological markers at the molecular level, enabling accurate diagnosis and monitoring of diseases. The dynamics within this market are driven by several factors, including technological advancements, increasing demand for personalized medicine, and growing awareness about early disease detection. With rapid developments in genomics and proteomics research, there has been a surge in the adoption of advanced diagnostic tools such as PCR machines, DNA sequencers, microarrays, and mass spectrometers. These instruments play a crucial role in identifying genetic mutations or alterations associated with various diseases like cancer or infectious pathogens.

Key Instruments and Platforms:

Polymerase Chain Reaction (PCR) Systems: PCR instruments amplify and analyze DNA or RNA segments, allowing for the detection of specific genetic sequences. Real-time PCR systems provide quantitative results and are widely used in various diagnostic applications.

Next-Generation Sequencing (NGS) Systems: NGS platforms analyze DNA or RNA sequences on a large scale, enabling the detection of genetic variations, mutations, and gene expression levels. NGS has revolutionized genomic analysis and personalized medicine.

Microarrays: DNA microarrays can analyze thousands of genes simultaneously, making them valuable for gene expression profiling, genotyping, and detection of genetic variants.

Mass Spectrometers: Mass spectrometry-based platforms analyze proteins and peptides, facilitating the identification of disease markers and the study of proteomics.

In-situ Hybridization Systems: These systems visualize the location of specific nucleic acid sequences within tissue samples, aiding in the diagnosis of diseases like cancer.

Digital PCR Systems: Digital PCR provides absolute quantification of nucleic acids, enhancing sensitivity and precision in detecting rare genetic mutations or pathogens.

Applications of Molecular Diagnostics Instruments:

Infectious Disease Diagnostics: Molecular diagnostics instruments are widely used to detect pathogens such as viruses, bacteria, and fungi. They play a critical role in diagnosing diseases like HIV, hepatitis, influenza, and COVID-19.

Cancer Diagnostics: Molecular testing helps identify genetic mutations and biomarkers associated with different types of cancer, guiding treatment decisions and monitoring patient response.

Genetic Testing: These instruments are used for carrier testing, prenatal testing, newborn screening, and genetic counseling to assess the risk of inherited disorders.

Pharmacogenomics: Molecular diagnostics aid in tailoring drug therapies based on an individual's genetic makeup, maximizing treatment effectiveness and minimizing adverse effects.

Key Players and Market Landscape:

The molecular diagnostics instruments market is characterized by a range of established companies and emerging players. Prominent manufacturers include Thermo Fisher Scientific, Roche Diagnostics, QIAGEN, Abbott Laboratories, Illumina, and Bio-Rad Laboratories.

Future Outlook:

The molecular diagnostics instruments market is expected to witness continued growth driven by technological advancements, increased adoption of precision medicine, and the ongoing need for accurate and rapid disease detection and monitoring.

Browse 235 pages report Molecular Diagnostics Instruments Market By Technology (Polymerase Chain Reaction (PCR), Hybridization, DNA sequencing, Microarray, Isothermal Nucleic Acid Amplification Technology (INAAT), Others) By Application (Infectious diseases, Oncology, Genetic testing, Blood screening) - Growth, Future Prospects & Competitive Analysis, 2016 – 2030)- https://www.credenceresearch.com/report/molecular-diagnostics-instruments-market

Molecular Diagnostics Instruments Market Recommendations:

Invest in Technology Advancements: Stay at the forefront of technological innovations by investing in research and development efforts that enhance the capabilities and efficiency of molecular diagnostics instruments. Embrace emerging technologies such as artificial intelligence, machine learning, and automation to streamline workflows, improve accuracy, and expedite data analysis.

Quality Assurance and Standardization: Prioritize rigorous quality control and validation processes to ensure the accuracy, reliability, and reproducibility of molecular diagnostic tests. Adherence to regulatory guidelines and industry standards is essential to maintain confidence in test results and promote patient safety.

Collaborate Across Disciplines: Foster interdisciplinary collaborations between molecular biologists, clinicians, bioinformaticians, and engineers to leverage diverse expertise for comprehensive diagnostic solutions. Collaborative efforts can lead to the development of integrated platforms that offer seamless sample processing, analysis, and interpretation.

Focus on User-Friendly Design: Design molecular diagnostics instruments with user-friendly interfaces, intuitive workflows, and clear data visualization to facilitate ease of use by laboratory professionals and clinicians. Intuitive instruments enhance efficiency, reduce errors, and increase adoption rates.

Educate and Train Personnel: Provide comprehensive training programs for laboratory personnel and healthcare professionals to ensure proficient operation of molecular diagnostics instruments and accurate interpretation of test results. Continuous education empowers users to harness the full potential of these technologies.

Data Integration and Interpretation: Develop robust bioinformatics tools and software solutions that enable efficient data integration, analysis, and interpretation. User-friendly interfaces and automated algorithms can assist in transforming complex molecular data into clinically actionable insights.

Adopt a Patient-Centric Approach: Prioritize patient needs and clinical relevance when designing assays and selecting molecular diagnostics instruments. Tailor diagnostic solutions to address specific healthcare challenges, improve disease detection, and guide personalized treatment decisions.

Global Access and Equity: Work towards ensuring global access to molecular diagnostics instruments, especially in resource-limited settings. Develop cost-effective solutions that can be deployed in diverse healthcare settings, contributing to equitable healthcare delivery.

Regulatory Compliance: Stay informed about evolving regulatory requirements and compliance standards for molecular diagnostics. Proactively engage with regulatory authorities to navigate the approval process and ensure the timely launch of validated assays and instruments.

Continuous Research and Validation: Encourage ongoing research and validation studies to demonstrate the clinical utility, cost-effectiveness, and patient outcomes associated with molecular diagnostics instruments. Collaborate with healthcare providers and researchers to generate robust evidence supporting the adoption of these technologies.

Why to Buy This Report-

The report provides a qualitative as well as quantitative analysis of the global Molecular Diagnostics Instruments Market by segments, current trends, drivers, restraints, opportunities, challenges, and market dynamics with the historical period from 2016-2020, the base year- 2021, and the projection period 2022-2028.

The report includes information on the competitive landscape, such as how the market's top competitors operate at the global, regional, and country levels.

Major nations in each region with their import/export statistics

The global Molecular Diagnostics Instruments Market report also includes the analysis of the market at a global, regional, and country-level along with key market trends, major players analysis, market growth strategies, and key application areas.

Browse Full Report: https://www.credenceresearch.com/report/molecular-diagnostics-instruments-market

Visit: https://www.credenceresearch.com/

Related Report: https://www.credenceresearch.com/report/poc-molecular-diagnostics-market

Related Report: https://www.credenceresearch.com/report/remote-patient-monitoring-devices-market

Browse Our Blog: https://www.linkedin.com/pulse/molecular-diagnostics-instruments-market-size-expected-singh

Browse Our Blog: https://medium.com/@priyanshi_97937/molecular-diagnostics-instruments-market-analysis-with-size-revenue-growth-drivers-and-forecast-3c1871e406ab

About Us -

Credence Research is a viable intelligence and market research platform that provides quantitative B2B research to more than 10,000 clients worldwide and is built on the Give principle. The company is a market research and consulting firm serving governments, non-legislative associations, non-profit organizations, and various organizations worldwide. We help our clients improve their execution in a lasting way and understand their most imperative objectives. For nearly a century, we’ve built a company well-prepared for this task.

Office No 3 Second Floor, Abhilasha Bhawan, Pinto Park, Gwalior [M.P] 474005 India

0 notes

sapanas · 5 years ago

Text

Microarray Analysis Market Research Report - 2020 | Global Industry Size, Share, Growth, Analysis Forecast To 2023

“The Latest Research Report Global Microarray Analysis Market By 2023 provides information on Market Size, Analysis, Shares, Forecast, Emerging Technologies and Company Profiles for key Industry Participants – Market Research future”

Microarray Analysis Market Overview:

global microarray analysis market is expected to grow at a CAGR 9.8% during the forecast period 2017-2023.

A microarray can be defined as a multiplex lab-on-a-chip that has a two-dimensional array on a solid substrate to perform tests for various end users. It enables researchers to investigate and address subjects that were often counted as non-traceable. The process allows quick analysis of an expression of many genes quickly but with great efficiency. The process involves the hybridization of an mRNA molecule and the DNA template from which the mRNA has been collected. Collection of multiple samples form an array.

Read more news on: https://www.medgadget.com/2019/01/microarray-analysis-market-set-for-big-growth-by-qiagen-agilent-technologies-bio-rad-laboratories-illumina-inc-etc-market-research-future.html

Such extensive researches are now providing substantial traction to the pharmaceutical sector. Also, genetic testing can gain sufficiently from the microarray testing segment. These procedures would further gain momentum due to hike in healthcare expenditure. Owing to these features, the microarray analysis market growth can expect hike in valuation in the coming years.

Microarray Analysis Market Segmentation:

The study on the global market for microarray analysis can be formed by including segments like application, type, product type, and end-user. These segments are carriers of various factors that can be explored in the coming day for better understanding of the global market.

By type, microarray analysis market report can be segmented into chemical compound microarrays, tissue microarrays, glycan arrays, protein microarrays, phenotype microarrays, DNA microarrays, and cellular microarrays. The segment for DNA microarrays has the largest market share as its extensive use in diverse applications like pharmaceuticals, hospitals & clinics, diagnostic centers, ambulatory care centers, academic & research institutes, and biotechnology can impact the market notably.

By application, microarray analysis market share integrated drug discovery, disease diagnosis, research, genotyping, genomics, forensic analysis, proteomics, and toxicological research. The drug discovery segment has the better opportunity to score the highest CAGR during the review period due to growing need for personalized drug.

By product type, microarray analysis market includes reagent kits, reagents, DNA chips, instruments, primers, and buffers. The instrument segment covers Multi-Channel (MC) instrument, hybridization oven, centrifuge, scanner, target preparation instrument, slide imprinters, and others.

By end-users, microarray analysis market comprises academic & research institutes, pharmaceuticals, diagnostic centers, hospitals & clinics, biotechnology, ambulatory care centers, and others.

Microarray Analysis Market Regional Analysis:

Region-specific study of the market for microarray analysis spans across namely, Europe, the America, and Asia Pacific (APAC) where revenue generation would be pretty high and the Middle East and Africa (MEA) where the market would be restricted due to the presence of poor countries.

The American region has the better opportunity to dominate the market with the infrastructural benefits and high growth of the investment possibilities. Also, the presence of major market players is expected to provide traction to the market.

Europe’s growing focus on the research and development segment to boost the healthcare sector with drug discovery, personalized medicine, and targeted therapy would provide the market traction.

The Asia Pacific market has the potential to score big due to the hike in the prevalence of government initiatives, genetic disorders, and increasing awareness among the people.

Microarray Analysis Market Competitive Landscape:

Various companies are getting involved in taking the global microarray industry ahead by contributing substantially both in terms of money and strategic moves. These companies are NextGen Sciences PLC, Discerna, Thermo Fisher Scientific, Illumnia Inc., Roche NimbleGen, ProteoGenix, Luminex Corporation, Agilent Technologies Inc., Applied Microarrays, Biomerieux SA, Sequenom Inc., Gyros AB, Affymetrix Inc., and others. MRFR listed these companies for a better understanding of various trends that can impact the market in the coming years. The work is backed by the recording of latest contributions made by these companies.

Browse Complete Report with TOC at https://www.marketresearchfuture.com/reports/global-microarray-analysis-market-777

In August 2019, in the Annual Peptide Drug Design and Delivery Summit, researchers announced the possibility of nanotechnology is growing rapidly in the healthcare industry. Among sectors, in which it can be used, microarray tests are expected to show some strong potential. These particles are more suitable to allow free movement in various parts of the body in comparison with traditional therapeutic molecules.

#Microarray Analysis Market #Microarray Analysis Market Size #Microarray Analysis Market Share #Microarray Analysis Market Growth #Microarray Analysis Market Analysis

0 notes

ssapkal-blog · 6 years ago

Text

Global Protein Labeling Market

Global protein labeling market was valued US$ 1.68 Bn in 2017 and is expected to reach US$ 4.62 Bn by 2026, at a CAGR of 13.48 % during a forecast period.

Proteins are important nutrients for the human body as well as they are one of the building blocks of body tissue and can also serve as a fuel source. Protein labelling holds properties such as high force output & energy density, rapid response time, easy controllability, and low power consumption.

Rising demand for proteomics research and increasing demand for genome sequencing are major driving factors of the market. Increasing healthcare expenses and growing R & D investments are also boosting the global protein labeling market. Irregularity in protein labeling procedure and strict government regulations are key challenges of the global protein labeling market.

Technological improvement and active pricing of protein-labeling technology products are the major opportunities of the market. However, Lack of skilled professionals and inadequate applications of protein-labeling products are limiting the growth of the market.

Reagents are expected to lead the market during the forecast period owing to the increasing demand for peptide binding agents and growing R & D activities. Reagents contain various enzymes, buffers, solutions, stabilizers, dyes, and antibody components, which are usually required and used in the protein-labeling process. The services segment is expected to witness lucrative growth owing to increased outsourcing of technical & expert workflow procedures.

Mass spectrometry (MS) is a systematic technique that ionizes chemical species and sorts the ions based on their mass-to-charge ratio. Mass spectrum measures the masses within a sample and used in many different fields and also applied to pure samples as well as complex mixtures. A protein microarray is a high-amount method used to track the relations & activities of proteins and to determine their function on a large scale. The large numbers of proteins can be tracked in parallel is increasing the growth of the protein microarray segment in the global protein labeling market.

North America is estimated to hold the largest share and revenue of the market during the forecast period owing to the growing use of protein labeling applications in North America. North America generates highest revenues across the globe owing to continuing projects on gene expression control, protein-protein interaction, and in-vivo quantitative proteomics. Canada is leading the lucrative growth owing to the growing number of research projects focused on improving healthcare solutions.

Key player operating in the global protein labeling market are General Electric Company, Kaneka Corporation, LI-COR, Inc., Merck & Co., Inc., New England Biolabs, Inc., PerkinElmer, Inc., Promega Corporation, F. Hoffmann-LA Roche AG, Seracare Life Sciences, Inc., and Thermo Fisher Scientific, Inc, Qiagen N.V., Active Motif, Inc., Takara Bio USA, Inc., Candor Bioscience GMBH, Innova Biosciences Ltd., Luminex Corporation, Bio-Rad Laboratories, Agilent Technologies, Inc., Caprion Biosciences, Nanotemper Technologies GMBH, and Biotium, Inc.

The report covers a comprehensive study of major market drivers, restrains, opportunities, challenges, PESTEL, Porters, SWOT, and technological forecasting in the market.

For More Information Visit@ https://www.maximizemarketresearch.com/market-report/global-protein-labeling-market/23253/

The Scope of Global Protein Labeling Market:

Global Protein Labeling Market, by Labelling Method:

• In Vitro Labeling • In Vivo Labeling • Bio orthogonal Labeling

Global Protein Labeling Market, by Product Type:

• Reagents • Kits • Services

Global Protein Labeling Market, by Application:

• Cell-Based Assays • Fluorescence Microscopy • Mass Spectrometry • Immunological Techniques • Protein Microarray

Global Protein Labeling Market, by End-User:

• Immuno-Biochemistry Labs • Contract Research Organization • Academic Institutes • Research Laboratories • Hospitals & Diagnostic Centers

Global Protein Labeling Market, by Region:

• North America • Europe • Asia-Pacific • South America • Middle East & Africa

Key Player Operating In the Global Protein Labeling Market:

• General Electric Company • Kaneka Corporation • LI-COR, Inc. • Merck & Co., Inc. • New England Biolabs, Inc. • PerkinElmer, Inc. • Promega Corporation • F. Hoffmann-LA Roche AG • Seracare Life Sciences, Inc. • Thermo Fisher Scientific, Inc • Qiagen N.V. • Active Motif, Inc. • Takara Bio USA, Inc. • Candor Bioscience GMBH • Innova Biosciences Ltd • Luminex Corporation • Io-Rad Laboratories • Agilent Technologies, Inc. • Caprion Biosciences • Nanotemper Technologies GMBH • Biotium, Inc.

This Report Is Submitted By @Maximize Market Research Company

Customization of the report:

Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.

About Maximize Market Research:

Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

Contact info:

Name: Lumawant Godage

Organization: MAXIMIZE MARKET RESEARCH PVT. LTD.

Email: [email protected]

Address:Omkar Heights, Sinhagad Road, Manik Baug, Vadgaon Bk,Pune, Maharashtra 411051, India.

Contact: +919607195908

#Protein Labeling Market

0 notes

healthcare00897 · 6 years ago

Text

Proteomics Market Research Provides an In-Depth Analysis on the Future Growth

Proteomics is a study of large scale proteomes. Proteomes are entire complements of protein expressed by a tissue, cell or organism. Proteomics aims to interpret the roles of large number of proteins made from combining 22 genetically-encoded amino acids. It helps to understand the structure, function, and interactions of the entire protein content in a specific organism. It is used to investigate protein expression, rates of protein production, degradation, modification of protein, protein movements in subcellular compartments, and protein-protein interaction.

Global Proteomics Market: Drivers

Key players in the market are focused on introducing new and improved proteomics techniques, which is expected to boost the proteomics market growth. For instance, in September 2017, Bruker Corporation launched timsTOF Pro system for parallel accumulation and serial fragmentation (PASEF) mass spectrometry— using proprietary trapped ion mobility spectrometry (TIMS) technology—to offer efficient data acquisition speed for shotgun proteomics.

Moreover, in October 2018, Bruker Corporation introduced a next-generation workflow for the timsTOF Pro mass spectrometer at Human Proteome Organization (HUPO). The platform for timsTOF Pro workflow includes large-scale, reproducible, and accurate collision cross section (ccs) values for tryptic peptides, fastpro, and ccs-based lipidomics workflow.

Moreover, in 2017, Diagenode, a provider of complete solutions for epigenetics research and sample preparation, in collaboration with PreOmics GmbH, developer and provider of innovative tools for MS-based proteomics, launched new streamlined sample preparation solution for proteomic analyses. The new solution was developed by combining PreOmics in-StageTip Kit (iST Kit) and the Diagenode Bioruptor sonication system to clean peptides for mass spectrometry (MS) analysis.

Global Proteomics Market: Regional Analysis

On the basis of region, the global proteomics market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

North America is expected to account for the largest market share in the proteomics market over the forecast period. The market growth is attributed to increasing collaboration and partnership activities by key players in this region. For instance, in November 2018, Thermo Fisher Scientific Inc. and Symphogen entered into a two-year collaborative partnership to deliver validated platform workflows for simplified characterization and quality monitoring of complex therapeutic proteins. Under this agreement, Symphogen would have access to Thermo Fisher’s Q Exactive Plus Orbitrap liquid chromatography-tandem mass spectrometry (LC-MS/MS) system with BioPharma Option for creating, testing, and validating the platform workflows for intact and native mass analysis of therapeutic monoclonal antibody (mAb) mixtures. Moreover, Symphogen will focus on the development of automated multi-attribute method (MAM) workflows for monitoring critical quality attributes of proteins using high-resolution accurate-mass mass spectrometry in a quality control environment.

Increasing government initiatives to promote research and development in proteomics, genomics, and bioinformatics is expected to propel Asia Pacific proteomics market growth during the forecast period. For instance, the 13th International Conference on Proteomics, Genomics, and Bioinformatics will be held on May 10-11, 2019 in Tokyo, Japan. The theme of the conference will be ‘Leading Edge Innovations in Life Sciences’ and the objective will be to explore the recent advancements and new methodologies that can be applied to the research to make proteomics and bioinformatics more advance. Target audience for the upcoming conference can be health professionals, researchers and scientists, management/business leaders and/or agents, government/non-government community groups or individuals, professors, psychiatrist, and therapists.

Key players operating in the global proteomics market include, Thermo Fisher Scientific Corporation, Agilent Technologies, Luminex Corporation, Danaher Corporation, Inc., Bio-Rad Laboratories, Inc., GE Healthcare, Waters Corporation, Caprion Proteomics Inc., PerkinElmer, Inc., Biognosys Inc., Bruker, Cell Signaling Technology, Inc., Newomics, Inc., Proteome Sciences, Applied Biomics, Inc., Courtagen Life Sciences, Inc., Xcelris Genomics., Center for Genomic Sciences, and Sera Prognostics, Inc.

Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/2493

Global Proteomics Market Taxonomy

By Product Type

Reagents and Kits

Microarray

Spectroscopy

X-ray Crystallography

Chromatography

Electrophoresis

Immunoassay

Protein Fractionation Reagents

Instruments

Protein Microarray

Spectrometry

Mass Spectrometry

NMR Spectroscopy

Chromatography

HPLC Systems

Ion Chromatography

Affinity Chromatography

Supercritical Fluid Chromatography

Electrophoresis

Gel Electrophoresis

Capillary Electrophoresis

Surface Plasmon Resonance

X-ray Crystallography

Protein Fractionation Systems

By Application

Drug Discovery

Clinical Diagnosis

Molecular Medicine

Others

By Region

North America

Europe

Asia Pacific

Latin America

Middle East

Africa

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Mr. Shah

Coherent Market Insights

1001 4th Ave, #3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: [email protected]

#Proteomics Market Proteomics Size Proteomics Trends

0 notes

market-research-future · 4 years ago

Text

North America Microarray Market SWOT Analysis, Growth and Future Outlook | Forecast to 2027

Market Highlights

The North America microarray market has been evaluated as slowly growing market and expected to continue in the similar way in the near future. A microarray is a multiplex lab-on-a-chip. It is a 2D array on a solid substrate, usually a glass slide or silicon thin-film cell, that assays large amounts of biological material using high-throughput screening miniaturized, multiplexed and parallel processing and detection methods. Globally the microarray market is dominated by DNA microarrays. The protein microarray is currently the fastest growing market. The use of peptide and carbohydrate microarrays is expanding. Tissue and cell microarrays are in their infancy stage and are developing slowly because of many complications in the process development. Microarray is one of the methods which was used for the diagnostic purpose in cancer research. But commonly used types like DNA microarray, antibody array have not been proven to be effective methods in case of the disease like cancer. So in order to deal with the limitations of other types, tissue microarray was developed. Tissue microarray is an effective diagnostic tool for cancer diagnosis. The more and more research is going on to make the tissue microarray more accurate and efficient. As the prevalence of cancer is spreading, the growth in the tissue microarray method is expected in the future.

On the other hand, as the technique is in its infancy stage, lots of mistakes and errors occur. The readings are not accurate many times. As the results are not reliable, it creates a hindrance in the growth of the tissue microarray method. Besides this, tissue microarrays are not recommended for certain types of studies. In certain tumors such as glioblastoma, there is such marked heterogeneity within tumors that this feature may not be adequately captured in tissue microarray studies. In addition, microarrays are also not very useful to study rare or focal events, such as number of immune cells in tumors. These are some of the factors that cause hindrance to the growth of the Tissue microarray market.

Taste the market data and market information presented through more than 16 market data tables and figures spread over 31 numbers of pages of the project report. Avail the in-depth TOC & market synopsis on “North America Microarray Market Research Report – Forecast to 2027.

Access Report Details @ https://www.marketresearchfuture.com/reports/north-america-microarray-market-2641

North America Microarray Market Players:

The major participants of this market are ABCAM, Asterand Bioscience, IHC World LLC, Novus Biologicals LLC (Acquired By BIO-TECHNE), Origene Technologies Inc, Pantomics, Inc, Protein Biotechnologies Inc, US Biomax, Inc., US Bioupton Int, Vitrovivo Biotech, LLC And Others

Regional Analysis:

North America tissue microarray market is segmented into two countries: United States, and Canada. U.S. is the largest market for tissue microarray. The U.S market for tissue microarray is expected to reach at USD 364.2 million by the end of the forecasted period. Canada is the second-largest market for tissue microarray which is expected to grow at a CAGR of 4.4%.

Segmentation:

North America Microarray market has been segmented on the basis of types which comprises of protein microarray, tissue microarray, and cellular microarray. On the basis of product, North America Tissue microarray market is segmented into paraffin tissue sections (FFPE), frozen tissue sections, and others. On the basis of applications, tissue microarray market is segmented into immunohistochemistry, in-situ hybridization, and others.

Browse More Reports at:

Veterinary Pain Management Market Research, Size, Share, Trends, Global Analysis, 2027

Cell Cycle Analysis Market Overview, Size, Growth, Industry Forecast to 2027

Prescribed Health apps Market Growth By Devices, Size and Trend Forecast To 2024

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

0 notes

decisionforsight · 4 years ago

Text

Global Biologics Market

Global Biologics Market Size, Share, Growth, Industry Trends and Forecast 2020-2030

Biologics are pharmaceutical products derived from living cells or micro-organisms. These are complex and large molecules comprising of proteins, peptides, nucleic acids, sugars, cellular structures or a combination of all the above. The biologics drug discovery process involves target identification, hit-to-lead stage, lead identification & optimization. Technologies applied for the development of biologics include genomics, proteomics, microarrays, cell cultures, phage display technologies and monoclonal antibody technologies. Biologics include genes that control production of vital proteins; proteins that control the action of other proteins and cellular processes; and modify human hormones or cells that produce products that suppress or activate the components of the immune system. They are used for the treatment of various diseases such as rheumatoid arthritis, ulcerative colitis, and other autoimmune diseases. The common side effects of biologics drugs observed are weakness, chills, allergic reactions, nausea, diarrhoea, itching, vomiting, injection side reaction, constipation, cough, headache, fever, shortness of breath, fever, dizziness, and others. The major biologics drugs presently available in the market are Humira, Remicade, Enbrel, Avastin and Herceptin. The global biologics market is projected to reach USD 559.6 billion by 2030 from USD 274.1 billion in 2020, at an approximate CAGR of 7.40%.

Download Sample Copy of the Report to understand the structure of the complete report (Including Full TOC, Table & Figures) @ https://www.decisionforesight.com/request-sample/DFS020111

Market Dynamics and Factors:

Rising prevalence of chronic diseases, incessant research and development activities, and continuous investment in biologics are the major factors attributing to the market growth of the biologics market across the globe. For instance, according to the World Health Organization (WHO), by 2020 chronic diseases would constitute around 75% of the total deaths worldwide. Cancer, autoimmune diseases, and diabetes attribute to almost 60% of the overall biologics market. In 2016, approximately 50% of the new molecular units approved by the Food and Drug Administration were biologics. Continuous advancements in cellular & gene therapy further catalyses the market because of its high efficacy and therapeutic outcome. Furthermore, other major factors such as rising expenditure on healthcare, increased availability of advanced diagnostics, and growing applications of monoclonal antibodies for the treatment of different diseases are also positively impacting the overall growth of the global biologics market. However, certain factors like the emergence of biosimilars, high cost of biologics, lack of oral absorption and operational challenges are restraining the market growth of the global biologics market

Market Segmentation :

Global Biologics Market – By Source

Microbial

Mammalian

Others

Global Biologics Market – By Product Type

Monoclonal Antibody

Interleukins

Vaccines

Growth Factors

Gene Therapy

Others

Global Biologics Market – By Disease Indication

Immunological Disorders

Cardiovascular Disorders

Hematological Disorders

Cancer

Arthritis

Diabetes

Others

Global Biologics Market – By Geography

North America

U.S.

Canada

Mexico

Europe

U.K.

France

Germany

Italy

Rest of Europe

Asia-Pacific

Japan

China

India

Australia

Rest of Asia Pacific

ROW

Latin America

Middle East

Africa

New Business Strategies, Challenges & Policies are mentioned in Table of Content, Request TOC at @ https://www.decisionforesight.com/toc-request/DFS020111

Geographic Analysis:

North America is expected to dominate the global biologics market in terms of market share during the forecast period. The presence of key market players, continuous R&D in the biologics field, growing prevalence of chronic disorders, and longer patent protection compared to other regions are the major factors attributing to the market dominance of the region. For instance, U.S. pharmaceutical companies’ account for almost 80% of the world’s R&D in health care biotechnology. The Asia Pacific region is anticipated to witness the fastest growth in the biologics market during the forecast period. Expansion of international players in developing nations contribute to the biologics market growth in the APAC region. For instance, Novartis AG wishes to launch its FDA approved treatment Kymriah in Japan. Additionally, there has been a spurt of heavy investments by Asian contract manufacturers in order to grab share in the global biologics market. Companies such as Samsung Biologics and Wuxi Biologics are anticipated to drive the market growth in the Asian region.

Competitive Scenario :

The key players operating in the global biologics market are –

AbbVie Inc., Amgen Inc., Pfizer Inc., Novartis AG, GlaxoSmithKline Plc, Bayer AG, Sanofi, Hoffman La-Roche, Samsung Biologics, Eli Lilly & Company, Merck & Co., Johnson & Johnson Services Inc.

Connect to Analyst @ https://www.decisionforesight.com/speak-analyst/DFS020111

How will this Market Intelligence Report Benefit You?

The report offers statistical data in terms of value (US$) as well as Volume (units) till 2030.

Exclusive insight into the key trends affecting the Global Biologics industry, although key threats, opportunities and disruptive technologies that could shape the Global Biologics Market supply and demand.

The report tracks the leading market players that will shape and impact the Global Biologics Market most.

The data analysis present in the Global Biologics Market report is based on the combination of both primary and secondary resources.

The report helps you to understand the real effects of key market drivers or retainers on Global Biologics Market business.

The 2021 Annual Global Biologics Market offers:

100+ charts exploring and analysing the Global Biologics Market from critical angles including retail forecasts, consumer demand, production and more

15+ profiles of top producing states, with highlights of market conditions and retail trends

Regulatory outlook, best practices, and future considerations for manufacturers and industry players seeking to meet consumer demand

Benchmark wholesale prices, market position, plus prices for raw materials involved in Global Biologics Market type

Buy This Premium Research Report@ https://www.decisionforesight.com/checkout/DFS020111

About Us:

Decision Foresight is a market research organization known for its reliable and genuine content, market estimation and the best analysis which is designed to deliver state-of-the-art quality syndicate reports to our customers. Apart from syndicate reports, you will find the best market insights, strategies that will help in taking better business decisions on subjects that may require you to develop and grow your business-like health, science, technology and many more. At Decision Foresight, we truly believe in disseminating the right piece of knowledge to a large section of the audience and cover the in-depth insights of market leaders across various verticals and horizontals.

Contact:

Email: [email protected]

For Latest Update Follow Us:

https://www.facebook.com/Decision-Foresight-110793387201935

https://twitter.com/DecisionFs

https://www.linkedin.com/company/decision-foresight/

0 notes

bhagyashribhole123 · 6 years ago

Text

Genotyping Market 2019 Size, Trends, Industry Analysis, Leading Players & Future Forecast by 2023

Genotyping Market Analysis

Genotyping helps users in understanding a living organism’s genetic structure such as humans, animals, plants and microorganisms. It is basically an organism’s genetic mapping that includes both DNA sequencing as well as sequenced DNA’s analysis. Genotyping has various uses in medicine, agriculture and basic scientific research. The Global Genotyping Market Size is projected to have a healthy growth at an exponential 22.5% CAGR during the forecast period (2018-2023).

There are several factors that are driving the growth of the genotyping market. These factors according to the MRFR report include advancements in technology, rising prevalence of target diseases namely Alzheimer’s, diabetes and cancer, introduction of new technologies which reduce errors and offer effective results, increasing R&D activities in healthcare, rise in genetic ailments, surge in need for personalized medication and decrease in genotyping service price. On the contrary, factors such as dearth of skilled professionals and unfavorable reimbursement policies may hamper the growth of the genotyping market.

Key Players

Leading players profiled in the genotyping market include Thermo Fisher Scientific Inc. (USA), Sequenom (USA), Qiagen (Germany), Illumina Inc. (USA), General Electric Company (USA), F. Hoffmann-La Roche Ltd. (Switzerland), Fluidigm Corporation (USA), Beckman Coulter Inc. (USA), Agilent Technologies Inc. (USA), and Affymetrix Inc. (USA).

Feb 2019 - Huasin and Genomica have entered into an agreement through which HuaSin availed exclusive rights for developing and producing HPV genotyping assay platform that is fully automated and uses Genomica’s technology. This genotyping technology will aid in detecting HPV in women prior to the development and spreading of cancer and expects it to also support vaccination programs that are long-needed and evolving.

Market Segmentation

Market Research Future report offers an all-inclusive segmental analysis of the genotyping market on the basis of product, end-user, application and technology.

Based on product, it is segmented into services, reagents and kits and instruments. Of these, reagents and kits will have the largest share in the market.

Based on end-user, the genotyping market is segmented into R&D centers, hospitals, diagnostic centers and academic institutes.

Based on application, it is segmented into personalized medicine, drug discovery and development, agriculture diagnostics and academic research. Of these, personalized medicine will lead the market and is expected to have the fastest growth.

Based on technology, the genotyping market is segmented into polymerase chain reaction (PCR), sequencing, microarray, mass spectrometry and capillary electrophoresis. Capillary electrophoresis is further segmented into single-strand conformation polymorphism (SSCP), restriction fragment length polymorphism (RFLP) and amplified fragment length polymorphism (AFLP). Microarrays is further segmented into peptide microarrays, MMChips, DNA microarrays and antibody microarrays. Sequencing is further segmented into sanger sequencing, pyrosequencing and next-generation sequencing. Of these, sequencing will lead the market during the forecast period.

Browse More Information:- https://www.marketresearchfuture.com/reports/genotyping-market-6635

Regional Analysis

Based on region, the genotyping market covers growth opportunities and latest trends across Americas, Europe, Asia Pacific and Middle East and Africa. Of these, Americas will garner highest share in the market. Owing to technology, North America will have a higher share over South America. The factors that can be attributed for the growth of the market in North America include presence of several key players, accessibility of advanced and innovative medical facilities, rising incidences of genetic disorders, and support from the government for research and development. The USA and Canada are the leading contributors in North America while in South America, Brazil and Argentina will be the key contributors. Europe will have the second largest share in the genotyping market owing to the region’s well-established healthcare sector. The market here is having a favorable growth owing to accessibility of latest and advanced medical facilities, increasing investment in research and development by pharmaceutical companies, presence of leading market players and various governments investing in research and development. Western Europe will have a bigger share than Eastern Europe. The genotyping market in the APAC region is projected to grow at the fastest pace owing to rising disposable income, increasing investment by key market players, stable healthcare sector which is growing gradually and supportive government policies. Here the key contributors are India, Japan, China, Australia and South Korea. On the other hand, the genotyping market in Middle East and Africa will have minimal share owing to most governments not giving priority to healthcare, dearth of healthcare facilities, lack of education, medical facilities having low standard, lack of advanced and innovative medical facilities, lack of awareness and presence of poor countries.

#Genotyping Market #Genotyping Market Size #Genotyping Market Share #Genotyping Market Growth #Genotyping Market Trends

0 notes

rishabh3210blog · 6 years ago

Link

Global microarray market trends, growth, industry research & analysis report by type (DNA, protein, peptide, tissue & cellular microarray) by application (drug discovery, diagnosis and prognosis, pharmacogenomics and theragnostic) forecast 2018-23

0 notes

sapanas · 5 years ago

Text

Covid 19 Impact on Genotyping Market Growth Prospects, Key Opportunities, Trends, Forecasts, Key Company Profiles And Industry Size, Share Analysis

Genotyping Market Analysis

The global genotyping market is projected to have a healthy growth at an exponential 22.5% CAGR during the forecast period (2018-2023). Genotyping helps users in understanding a living organism’s genetic structure such as humans, animals, plants and microorganisms. It is basically an organism’s genetic mapping that includes both DNA sequencing as well as sequenced DNA’s analysis. Genotyping has various uses in medicine, agriculture and basic scientific research.

Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/6635

Genotyping Market Segmentation

Market Research Future report offers an all-inclusive segmental analysis of the genotyping market on the basis of product, end-user, application and technology.

Based on product, it is segmented into services, reagents and kits and instruments. Of these, reagents and kits will have the largest share in the market.

Based on end-user, the genotyping market is segmented into R&D centers, hospitals, diagnostic centers and academic institutes.

Genotyping Market Regional Analysis

Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/genotyping-market-6635

Genotyping Market Key Players

#Covid 19 Impact on Genotyping Market #Genotyping Market #Genotyping Market Size #Genotyping Market Growth #Genotyping Market Analysis

0 notes

strategyr-blog · 7 years ago

Text

The Global Market for Biotechnology Instrumentation is Projected to Reach US$53.3 Billion by 2022

Expanding Biotech Research at the Back of Robust New Drug Development Activity to Drive the Biotechnology Instrumentation Market, According to a New Report by Global Industry Analysts, Inc.

GIA launches comprehensive analysis of industry segments, trends, growth drivers, market share, size and demand forecasts on the global Biotechnology Instrumentation market. The global market for Biotechnology Instrumentation is projected to reach US$53.3 billion by 2022, driven by the robust R&D investments in new drug development, enhancements in performance of existing technology platforms, and conceptualization of new measurement and instrument configuration systems.

Biotechnology has evolved into a wide and diverse industry over the years having undergone a transition from mere application of cultured microorganisms and animal and plant breeding processes to an advanced industry involving the use of various scientific and engineering disciplines. Today, biotechnology has become an important part of virtually every sector of the economy including chemical, agrochemical, beverage, food processing, healthcare, forensics, agriculture environmental monitoring, and animal husbandry, among others. The pharmaceuticals industry is the principal force driving the biotechnology revolution, primarily due to constant exploration for new drugs. Biotechnology instruments and tools are used in universities and pharmaceutical company research labs for cellular and molecular examination. Analytical instruments such as centrifuges, DNA synthesizers, protein analyzers and bio robotics are used by research laboratories in universities, and biotechnology and pharmaceutical companies. Over the years use of bioinstrumentation techniques has become simple and more accessible.

Demand for faster and economical ways to produce drugs for the pharmaceutical industry, proteomics, genomics, functional genomics and combinatorial chemistry have led to the advancements of bioinstrumentation in recent years. In addition to the human genome project that created ripples in the areas of proteomics and genomics, the market is also driven by considerable enhancements in performance of prevailing technology platforms, and conceptualization of new measurement and instrument configuration systems. Continuous advancements promise growth opportunities in clinical diagnostics, life sciences research, and personalized medicine. The evolution of Next-Generation Sequencing (NGS) technology has resulted in development of advanced molecular tools to facilitate the profiling the transcriptome and aid in the detection and analysis of noncoding RNA to understand cancer biology and create new therapeutic targets for cancer. The industry is expected to gain from expanding research and breakthroughs in areas such as molecular biology, next generation sequencing, and bioinformatics to analyze and interpret information at molecular level.

As stated by the new market research report on Biotechnology Instrumentation, the United States represents the largest market worldwide. Asia-Pacific is forecast to record the fastest CAGR of 9.5% over the analysis period led by robust growth from the Chinese and Indian markets. Growing population, rising per capita income, increasing government spending and increasing focus on research and development activity are the major factors contributing to the growth in the region.

Major players in the market include Abbott Laboratories, Agilent Technologies Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., Bruker Corporation, GE HealthCare, Gilson Inc., Harvard Bioscience Inc., Hitachi High-Technologies Corp., Illumina Inc., Lonza Group AG, PerkinElmer Inc., Roche Diagnostics, Shimadzu Corp., Siemens Healthineers, Thermo Fisher Scientific Inc., and Waters Corp. among others.

The research report titled “Biotechnology Instrumentation: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, issues, drivers, mergers, acquisitions and other strategic industry activities of global companies. The report provides market estimates and projections in value terms for all major geographic markets such as the US, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia and Rest of Europe), Asia-Pacific (China, India and Rest of Asia-Pacific), Latin America (Brazil, Mexico and Rest of Latin America) and Rest of World. Product segments analyzed include DNA Sequencing Systems, DNA Synthesizers, Electrophoresis Systems, Immunoassay Systems, Laboratory Automation, Liquid Chromatography Systems, Mass Spectrometry, MicroArrays, and Protein/Peptide Synthesizers.

For enquiries e-mail us at [email protected] or [email protected]. To connect with us, visit our LinkedIn page.

#Biotechnology Instrumentation #Laboratory Equipment and Supplies

0 notes

healthy-insights · 8 years ago

Text

Intensifying Research in Drug Discovery to Increase Adoption of Genomics and Proteomics Technologies in Healthcare Facilities, reports TMR

The global genomics and proteomics reagent and analytical instruments market has seen the emergence of new regional players, many of whom have successfully expanded beyond their original markets, reports Transparency Market Research (TMR) in a new study. Due to the high level of competitive rivalry within the market, the companies operating in this field are impelled to adopt highly competitive pricing and marketing strategies. The top three market players accounted for approximately 52.4% in the global genomics and proteomics market in 2012. The leading market player is Agilent followed by Thermofisher, and Life Technologies.

As the genomics and proteomics market is highly fragmented, the players in the market are focusing on intense pricing strategies such as heavy discounts. Due to low loyalty, companies venturing in the genomics and proteomics market have fewer prospects of long term business opportunities. This can be only secured by having long term association with clients and meeting their requirements, says TMR.

Browse Global Strategic Business Report: http://www.transparencymarketresearch.com/proteomics-market.html

Drug Discovery and Disease Identification to Boost Demand for Genomics and Proteomics Technologies

With the increasing awareness regarding drug discovery and disease management, the demand for genomics and proteomics technologies is also rising. The growth in the genome working mechanism has influenced researchers to take up researches in the field of rare genetic and central nervous system disease. The escalating demand for genomics and proteomics from HIV, cancer, and diabetes diagnostics is also expected boost the growth of the market. The increasing need for personalized medicine and companion diagnostics is also one the significant factor aiding the growth of the genomics and proteomics market. The growing awareness about prenatal and presymptomatic testing is also one of the major drivers for the adoption of genomics and proteomics techniques.

The increasing investments by developing countries such as India, China, and Brazil in healthcare and medical research for drug discovery are also likely to drive the growth of the global genomics and proteomics technology market.

High Cost of Technology to Hamper Implementation of Genomics and Proteomics Technologies in Developing Countries

The initial set up cost of genomics and proteomics technology is extremely expensive, making it difficult for developing countries to set them up. The required capital investment for setting up a modern laboratory is certain to reach several hundred millions of dollars. High end technological systems comprising next-gen sequencers, and mass spectrometers are considered to be out of reach for facilities in developing countries. Thus, the high cost of technology and expensive initial investment is anticipated to hinder the demand for genomics and proteomics technology in developing countries.

Collaboration among Global and Regional Companies to Help in Business Expansion

According to a TMR analyst, “The collaboration of global and regional research facilities is likely to provide vendors of genomics and proteomics technologies with substantial growth prospects. As there are sufficient epidemiological samples available from developing countries for carrying out diagnostic models and further enhancing data sets for disease testing, the collaborations between research facilities will help in the creation of commercial solutions for diseases, thus enhancing market growth.”

With favorable factors in dominance, the global genomics and proteomics market is expected rise at 12.1% CAGR between 2013 and 2019. The global genomics and proteomics market was valued at US$36.76 bn in 2015 and is projected to reach US$52.35 bn by the end of 2019. North America is expected to maintain its lead in the global market in terms of innovation in genomics and proteomics technology.

The review has been based on the findings of a TMR report titled, “Genomics and Proteomics Reagents, Research Kits and Analytical Instruments Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019.”

Download Exclusive Brochure of This Report :

http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=983

The global genomics and proteomics market is segmented into the following categories:

Genomics and Proteomics Market, by Reagent and Research Kits

Sample Preparation Kits

Purification Kits

Electrophoresis Kits

BioChips and Microarrays

Prepackaged Sample Preparation Kits for PCR

Prepackaged Sample Preparation Kits for Chromatography

Prepackaged Sample Preparation Kits for Mass Spectrometry

Prepackaged Sample Preparation Kits for Electrophoresis

Capillary Electrophoresis/li>

Gel Electrophoresis

DNA BioChips and Microarrays

Protein and Peptide BioChips and Microarrays

Genomics and Proteomics Market, by Analytical Instruments

Chromatography

Mass Spectrometry, by Analyzers

Thermal Cyclers

Next Generation Sequencing

Gas Chromatography

Liquid Chromatography

Tandem Mass Spectrometry

Time-Of-Flight Mass Spectrometry

Quadrupole Mass Spectrometry

Fourier Transform Mass Spectrometry

Others(Magnetic Sector, Orbitrap, Ion Trap)

Digital Thermal Cyclers

Conventional or Traditional Thermal Cyclers

Real-Time Thermal Cyclers

Genomics and Proteomics Market, by Geography

North America

Europe

Asia-Pacific

Rest of the World (RoW)

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: [email protected] Website: http://www.transparencymarketresearch.com

0 notes